Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – Time to Buy?

Pro Medicus Limited (OTCMKTS:PMCUF) gapped up prior to trading on Wednesday. The stock had previously closed at $129.76, but opened at $137.0250. Pro Medicus shares last traded at $137.0250, with a volume of 25 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Pro Medicus currently has a consensus rating of “Hold” and an average price target of $155.00.

Pro Medicus Price Performance

The firm’s 50-day simple moving average is $120.88 and its 200 day simple moving average is $110.99.

Pro Medicus Company Profile

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its solutions are designed to help hospitals, radiology practices and other providers store, manage, view and distribute medical images and related clinical information.

The company’s principal platform is Visage 7, an enterprise imaging system developed and commercialized through its wholly owned subsidiary, Visage Imaging. The platform supports the review of diagnostic studies such as computed tomography, magnetic resonance imaging and other medical images, with an emphasis on enterprise-wide access, workflow efficiency and advanced visualization.

Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves healthcare customers in Australia, North America and Europe.